August 2007
Zymenex has received a gracious grant from THE BRITISH TRUST FOR THE MYELIN PROJECT of 50,000 EURO to help fund the ongoing clinical trial with Zymenex' recombinant enzyme Metazym, in patients suffering from the Lysosomal Disease, Metachromatic Leukodystrophy.